A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

NCT06953999 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

999

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine
DRUG: Ivonescimab, AK117 Placebo, Albumin-bound Paclitaxel, Gemcitabine
DRUG: Ivonescimab Placebo, AK117 Placebo, Albumin-bound Paclitaxel, Gemcitabine

Sponsor

Akeso